Biotech Stock News (ARWR) (GILD) (HRTX) (VRTX)

Arrowhead Research (NASDAQ:ARWR) On September 24, 2015 shares of Arrowhead were up as much as 20% after announcing positive phase 2a trial results for its Hepatitis B trial. Investors thought the results were good which is why the stock ended the day on the positive side. In addition to obtaining positive phase 2a Hep B … Read more

Biotech Stock News (OREX) (ABBV) (PCYC) (GILD) (OHRP)

Orexigen Therapeutics (OREX) Shares of Orexigen Therapeutics were up 40% on 3/3/15 when the company announced that early safety data showed that Contrave was not only safe to take but in addition it was able to reduce a patient’s risk of generating cardiovascular health issues such as a heart-attack. Contrave was approved by the FDA … Read more